Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...

Epiminder plans to launch its GO Minder system in the US during the first half of 2026 using funds from the IPO, which raised ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

Speaking to the media, Shuchit Pandey, neurophysician at Ahmedabad Civil Hospital, underscored the importance of dispelling misconceptions surrounding epilepsy. He noted that seizures, commonly ...

Epiminder shares have made a lacklustre start to life on the ASX, despite positive market developments in the US.

Melbourne-based Epiminder plans to use the funds from its initial public offering to commercialise a device it says could ...

Kennedy Krieger researchers discover port wine birthmarks strongly indicate Sturge Weber syndrome, which affects brain ...

Alicia V. Cabrera, MD Neurology of Central Florida ABOUT THE DOCTOR Dr. Cabrera is an adult neurologist who is ...

Sebastian Marquez ’16, MA ’19, Ph.D. ’20 honed research skills at the College of Engineering & Computing and cultivated ...

For Sebastian Marquez, biomedical engineering represents the perfect convergence of two worlds that he is passionate about: the innovation and ...